Vaxxinity, Inc.
VAXX
$0.0002
-$0.0153-98.71%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 44.31% | 31.72% | 18.98% | -0.87% | 57.25% |
| Total Depreciation and Amortization | -15.56% | 58.95% | 34.18% | 75.98% | 210.34% |
| Total Amortization of Deferred Charges | -7.69% | 0.00% | 0.00% | -7.14% | -51.85% |
| Total Other Non-Cash Items | -58.30% | -26.67% | 7.72% | -16.48% | -92.73% |
| Change in Net Operating Assets | -146.01% | -138.99% | -115.32% | -7.20% | -59.53% |
| Cash from Operations | 18.18% | -15.65% | -15.38% | -2.75% | -3.67% |
| Capital Expenditure | -41.78% | 60.56% | 83.30% | 75.88% | 76.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.97% | 92.54% | -- | -- | -- |
| Cash from Investing | -101.50% | 92.41% | 5,036.92% | 1,325.81% | 2,245.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -185.45% | -306.54% | -152.83% | -439.25% | 65.41% |
| Issuance of Common Stock | 0.00% | 93.10% | 250.89% | -96.69% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -187.16% | -385.90% | 2,000.00% | -4,200.00% | -100.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.55% | 78.59% | 231.69% | 41.20% | -77.31% |